SCHEMBL13367482

SCHEMBL13367482

Cc1cc(C)cc(N(C)c2ccc(C(C)(C)C)cc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.48
LMNA P02545 1/20 0.37
TYR P14679 1/20 0.37
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
ALDH1A1 P00352 4/20 0.35
HSD17B10 Q99714 2/20 0.35
RAB9A P51151 3/20 0.34
NPC1 O15118 2/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
MAPK1 P28482 1/20 0.34
KCNH2 Q12809 1/20 0.34
KDM4E B2RXH2 1/20 0.34
CNR2 P34972 1/20 0.33
NR1H4 Q96RI1 1/20 0.33
ALOX15 P16050 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
SLC2A1 P11166 1/20 0.33
KDM4C Q9H3R0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20172773 0.85 TSHR (0.68) TSHRLMNATYRALDH1A1HSD17B10
SCHEMBL1134090 0.85 TSHR (0.50) TSHRLMNATYRCYP1A2CYP2C19
SCHEMBL13367485 0.83 TSHR (0.43) TSHRALDH1A1RAB9ANPC1MAPK1
SCHEMBL13367384 0.82 KIF11 (0.41) MAPTKDM4CKIF11
SCHEMBL20172774 0.82 TSHR (0.46) TSHRLMNATYRCYP1A2CYP2C19
SCHEMBL15158563 0.82 TSHR (0.50) TSHRLMNATYRCYP1A2CYP2C19
SCHEMBL13367375 0.81 ALDH1A1 (0.52) TSHRCYP2C19ALDH1A1HSD17B10MAPT
SCHEMBL21846191 0.79 TACR1 (0.38) TSHRLMNACYP2C19ALDH1A1RAB9A
SCHEMBL24145271 0.79 KIF11 (0.52) TSHRLMNATYRALDH1A1HSD17B10
SCHEMBL20210327 0.78 TSHR (0.41) TSHRLMNATYRCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OR10J3, OCIAD1, OCIAD2 TSHR 3278/4885LMNA 4085/4885TYR 971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.